Cabozantinib
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Cabozantinib Product Information
Cabozantinib is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Cabozantinib. The product is supplied by Clearsynth under CAT No. CS-L-00116.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Cabozantinib
CAS No.
849217-68-1
CAT No.
CS-L-00116
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C28H24FN3O5
Molecular Weight
501.51
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Cabozantinib is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Cabozantinib.
Overview
"Cabozantinib is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell typ"
Synonyms
Cabozantinib
Application Notes
"Cabozantinib is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell typ"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.